(ii)To approve the increase in the Company's capital, within the limit of its authorized capital, in the amount of three billion, two-hundred and twelve million, four-hundred and seventy thousand, nine-hundred and sixty-five Reais (R$ 3,212,470,965.00), which will changefrom R$ 5,741,284,174.75 (five billion, seven hundred and forty one million, two hundred and eighty four thousand, one hundred and seventy four Reais and seventy five cents)to eight-billion, nine-hundred fifty-three million, seven-hundred fifty-five thousand, one-hundred and thirty-nine Reais and seventy-five cents (R$ 8,953,755,139.75), through the issuance of 116,817,126 (one hundred sixteen million, eight hundred seventeen thousand and one hundred twenty-six) new common shares, each in the amount of R$ 27.50 (twenty seven reais and fifty cents), all registered, book-entry and without par value (“Common Shares”), which are object of the Offering (“Shares of the Offering”), increasing the Company's capitalfrom 1,017,914,746 (one billion, seventeen million, nine hundred and fourteen thousand, seven hundred and forty six) common sharesto 1,134,731,872 (one billion, one hundred thirty-four million, seven hundred thirty-one thousand and eight-hundred and seventy-two) common shares, excluding the preemptive right of the Company’s current shareholders, pursuant to Article 172, item I, of the Law No. 6,404, as of December 15, 1976, and Article 5, paragraph 2nd of the Company’s bylaws. There was no issuance of Additional Shares in the Offering. In accordance with Article 5-B of CVM Instruction 476, the amount of the Shares of the Offering may be increased by the Overallotment Shares in up to fifteen percent (15%) of the total Shares of the Offering, that is, up to 17,522,568 Common Shares (“Overallotment Shares”), in accordance with the option to be granted to the Stabilizing Agent (as defined in the minutes of the Board of Directors Meeting of the Company dated May 29, 2019), under the terms of the Underwriting Agreement, to be used exclusively to implement the share price stabilization activities (“Greenshoe Option”). The Stabilizing Agent, through the Brokerage Firm (as defined in the minutes of the Board of Directors Meeting of the Company dated May 29, 2019), shall have the exclusive right, as of the date of execution of the Underwriting Agreement, including, and for a period up to thirty (30) days as of the date of the beginning of trading of the Shares of the Offering in B3, to exercise the Greenshoe Option, fully or partially, in one or more times, after notifying the other Underwriters, provided that the decision to overallot the Shares is agreed among the Stabilizing Agent and the other Underwriters when determining the Price Per Share. |
(iii) To approve the Board of Directors’ verification of the subscription of 116,817,126 (one hundred sixteen million, eight hundred seventeen thousand and one hundred twenty-six) Shares and the resulting approval of the Company's capital increase, due to the resolutions taken in items (i) and (ii) above, in the amount of three billion, two-hundred and twelve million, four-hundred and seventy thousand, nine-hundred and sixty-five Reais (R$ 3,212,470,965.00), through the issuance of 116,817,126 (one hundred sixteen million, eight hundred seventeen thousand and one hundred twenty-six) new common shares, all registered, book-entry and without par value. |
(v) To approvethe acts that the Company’s Board of Executive Officers has performed up to this date, solely and exclusively, for purposes of carrying out the Offering and to authorize the Company’s Board of Executive Officers to take all measures and perform all acts to implement the resolutions approved in this meeting, including, but not limited to representing the Company before the CVM, B3, ANBIMA -Associação Brasileira das Entidades dos Mercados Financeiro e de Capitais, the New York Stock Exchange and the Securities and Exchange Commission, as they may be necessary, and to perform, or cause to be performed, any acts and/or to negotiate, approve and execute any agreements, communications, notifications, certificates, documents or instruments deemed necessary or appropriate to carry out the Offering. |